Walgreens posted net income of $821 million in the three months ended Nov. 30, compared to $1.05 billion reported in the same period a year prior. The company partially attributed the decline to its investment in China-based Guangzhou Pharmaceuticals Corp.
At the same time, Walgreens’ net sales increased 7.9 percent to $30.7 billion. Specifically, Walgreens’ first quarter pharmacy sales jumped 8.9 percent year over year to $22.5 billion. Walgreens’ relationship with Prime Therapeutics, and their formation of AllianceRx Walgreens Prime, boosted prescription volumes.
More articles on business:
Business loan growth was sluggish in 2017 and no one knows why
Unemployment is down: Why aren’t wages and inflation going up?
Amazon’s Prime service ships 5B+ items in 2017
